node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
CNR1 | DRD2 | ENSP00000358511 | ENSP00000354859 | cannabinoid receptor 1 (brain) | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | 0.958 |
CNR1 | GNAI1 | ENSP00000358511 | ENSP00000343027 | cannabinoid receptor 1 (brain) | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 | 0.956 |
CNR1 | GNAI3 | ENSP00000358511 | ENSP00000358867 | cannabinoid receptor 1 (brain) | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3; Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. G(k) is the stimulatory G protein of receptor- regulated K(+) channels. The active GTP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane. May play a role in cell division | 0.956 |
CNR1 | GPR18 | ENSP00000358511 | ENSP00000343428 | cannabinoid receptor 1 (brain) | G protein-coupled receptor 18; Receptor for N-arachidonyl glycine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. May contribute to regulation of the immune system | 0.951 |
CNR1 | GPR55 | ENSP00000358511 | ENSP00000375893 | cannabinoid receptor 1 (brain) | G protein-coupled receptor 55; May be involved in hyperalgesia associated with inflammatory and neuropathic pain (By similarity). Receptor for L- alpha-lysophosphatidylinositol (LPI). LPI induces Ca(2+) release from intracellular stores via the heterotrimeric G protein GNA13 and RHOA. Putative cannabinoid receptor. May play a role in bone physiology by regulating osteoclast number and function | 0.967 |
CNR1 | NPY | ENSP00000358511 | ENSP00000242152 | cannabinoid receptor 1 (brain) | neuropeptide Y; NPY is implicated in the control of feeding and in secretion of gonadotrophin-release hormone | 0.956 |
CNR1 | POMC | ENSP00000358511 | ENSP00000264708 | cannabinoid receptor 1 (brain) | proopiomelanocortin; ACTH stimulates the adrenal glands to release cortisol | 0.954 |
CNR1 | SST | ENSP00000358511 | ENSP00000287641 | cannabinoid receptor 1 (brain) | somatostatin; Somatostatin inhibits the release of somatotropin | 0.951 |
CNR1 | TRPV1 | ENSP00000358511 | ENSP00000382659 | cannabinoid receptor 1 (brain) | transient receptor potential cation channel, subfamily V, member 1; Receptor-activated non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli. Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. May be involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Acts as ionotropic endocannabinoid receptor with central neuromodulatory effects. Trigger [...] | 0.992 |
CNR1 | VR1 | ENSP00000358511 | ENSP00000459962 | cannabinoid receptor 1 (brain) | transient receptor potential cation channel subfamily V member 1 ; Receptor-activated non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli. Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. May be involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Acts as ionotropic endocannabinoid receptor with central neuromodulatory effects. Triggers [...] | 0.992 |
DRD2 | CNR1 | ENSP00000354859 | ENSP00000358511 | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | cannabinoid receptor 1 (brain) | 0.958 |
DRD2 | GNAI1 | ENSP00000354859 | ENSP00000343027 | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 | 0.909 |
DRD2 | GNAI3 | ENSP00000354859 | ENSP00000358867 | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3; Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. G(k) is the stimulatory G protein of receptor- regulated K(+) channels. The active GTP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane. May play a role in cell division | 0.959 |
DRD2 | GPR18 | ENSP00000354859 | ENSP00000343428 | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | G protein-coupled receptor 18; Receptor for N-arachidonyl glycine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. May contribute to regulation of the immune system | 0.901 |
DRD2 | GPR55 | ENSP00000354859 | ENSP00000375893 | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | G protein-coupled receptor 55; May be involved in hyperalgesia associated with inflammatory and neuropathic pain (By similarity). Receptor for L- alpha-lysophosphatidylinositol (LPI). LPI induces Ca(2+) release from intracellular stores via the heterotrimeric G protein GNA13 and RHOA. Putative cannabinoid receptor. May play a role in bone physiology by regulating osteoclast number and function | 0.906 |
DRD2 | NPY | ENSP00000354859 | ENSP00000242152 | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | neuropeptide Y; NPY is implicated in the control of feeding and in secretion of gonadotrophin-release hormone | 0.937 |
DRD2 | POMC | ENSP00000354859 | ENSP00000264708 | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | proopiomelanocortin; ACTH stimulates the adrenal glands to release cortisol | 0.943 |
DRD2 | SST | ENSP00000354859 | ENSP00000287641 | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | somatostatin; Somatostatin inhibits the release of somatotropin | 0.948 |
GNAI1 | CNR1 | ENSP00000343027 | ENSP00000358511 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 | cannabinoid receptor 1 (brain) | 0.956 |
GNAI1 | DRD2 | ENSP00000343027 | ENSP00000354859 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 | dopamine receptor D2; Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity) | 0.909 |